RNAi therapeutics are revolutionizing disease treatment, with six approved therapies primarily targeting rare genetic disorders. As many potential disease targets still lack effective treatments, RNAi-based therapies are becoming increasingly crucial in biopharmaceutical research. BOSTON,…